DHC schedules November 2 results: DHC stock gains 4.75 percent

Published on 10/20/2026 at 22:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

S&P Global revised DHC's outlook to positive on October 9, 2026. DHC stock costs EUR 6.89 on October 20, up 4.75 percent on Nasdaq.

Reporting date November 2, 2026

Diversified Healthcare Trust scheduled its third-quarter 2026 results for November 2, 2026.
S&P Global Ratings revised DHC's outlook to positive on October 9, 2026.
DHC stock costs EUR 6.89 at Lang & Schwarz on October 20, 2026 at 10:15 p.m. CEST, up 4.75 percent on Nasdaq.
DHC reported USD 365.39 million in second-quarter 2026 revenue against USD 370.80 million expected.

DHC, US25525P1075, Illustration mit AI erstellt.

Diversified Healthcare Trust (ISIN US25525P1075) will publish its third-quarter 2026 results after the Nasdaq close on November 2, 2026, followed by a conference call on November 3. Business Wire reported the schedule on October 6, 2026. The stock was trading at EUR 6.89 at Lang & Schwarz on October 20, 2026 at 10:15 p.m. CEST, up 4.75 percent on Nasdaq.

Credit outlook turns positive

S&P Global Ratings revised DHC's issuer outlook to positive from stable on October 9, 2026, while affirming the B-minus issuer credit rating. The agency cited stronger liquidity and balance-sheet progress after approximately USD 600.00 million of 2025 asset-sale proceeds were used mainly to retire debt.

The credit picture still carries a clear refinancing test. S&P Global Ratings said DHC's next material maturity is USD 500.00 million of senior unsecured notes due in February 2028. Cash stood at USD 116.80 million as of June 30, 2026, and the company had full access to a USD 150.00 million secured revolving facility.

How does the November date frame DHC?

The scheduled report follows second-quarter revenue of USD 365.39 million for the period ended June 30, 2026, compared with a FactSet estimate of USD 370.80 million. Normalized funds from operations were USD 0.16 per share, above the USD 0.15 consensus estimate, according to MarketScreener on August 3, 2026. The November release will show whether operating improvement is reaching revenue and cash generation.

Healthcare REIT peers remain larger

Healthcare Realty Trust (NYSE, USD): up 3.02 percent, P/E minus 67.71, market capitalization USD 6.2 billion. Welltower (NYSE, USD): up 2.01 percent, P/E 126.03, market capitalization USD 171.6 billion. DHC: up 4.75 percent on Nasdaq, market capitalization USD 1.9 billion. These figures place DHC at a much smaller equity value than the two larger healthcare property owners.

Dividend and portfolio dates

DHC set a quarterly dividend of USD 0.01 per share for shareholders of record on October 19, 2026, with payment scheduled for November 12, 2026, according to MarketScreener. DHC's portfolio comprised approximately USD 6.3 billion of healthcare properties as of June 30, 2026, including 23,797 senior living units and approximately 5.6 million square feet of medical office and life science space.

DHC's next dated milestones are the November 2, 2026 third-quarter results and the November 3, 2026 earnings call. For investors, the key comparison will be between the improved credit profile and the operating figures reported for the June quarter.

DHC trades higher before results

DHC stock stood at EUR 6.89 at Lang & Schwarz on October 20, 2026 at 10:15 p.m. CEST, up 4.75 percent on Nasdaq. The further course of trading is shown by the continuously updated real-time quote of DHC stock.